why choose us

First received: August 18, 2023

Clinical Trial: XG005 for Pain Control in Subjects Undergoing Bunionectomy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Pain

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of XG005 Tablets in Subjects Undergoing Bunionectomy

Brief Summary: This study will evaluate the safety, efficacy, and PK of low dose (750 mg) and high-dose (1250 mg) XG005 oral tablets compared with placebo in subjects undergoing bunionectomy.Subjects will be confined in the clinic from check-in through 72 hours post-surgery to monitor subject safety.

Read more